Solexa to Present at Leerink Swann & Company/MEDACorp Roundtable Conference
News May 05, 2006
Solexa, Inc. has announced that John West, chief executive officer of Solexa, and Linda Rubinstein, vice president & CFO, will make a presentation to the investment community at the Leerink Swann & Company/MEDACorp Roundtable Conference on Emerging Life Science Tools Products and Applications on Tuesday, May 9, 2006, at 2:15 p.m. Eastern Time (11:15 a.m. Pacific Time) at the Millennium Broadway Hotel in New York City.
Interested investors may gain access to a live audio webcast via the Internet by visiting the "Investors" section of the Company's Web site. The presentation will be archived on the Web site for 14 days.
In addition, Mr. West will participate in a panel discussion, "Emerging DNA Sequencing Technologies and Applications," moderated by John Sullivan and Irena Melnikova, Ph.D., of Leerink Swann.
The panel will also include other industry participants, including representatives of top-tier commercial and academic institutions.
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE